Skip to main content

Table 2 Histopathological aspects evaluated according to each subgroup

From: A comprehensive analysis of penile cancer in the region with the highest worldwide incidence reveals new insights into the disease

Parameters

Total n = 200

HPV n = 113

IHC n = 173

Surgical procedure

N (%)

N (%)

N (%)

  Preservative (exeresis)

7 (3.5)

0 (0.0)

5 (2.9)

  Total glansectomy

7 (3.5)

4 (3.5)

7 (4.0)

  Partial penectomy

145 (72.5)

80 (70.8)

126 (72.8)

  Total penectomy

28 (14.0)

19 (16.8)

24 (13.9)

  Emasculation

13 (6.5)

10 (8.8)

11 (6.4)

Topography

  Foreskin and/or coronal sulcus

8 (4.0)

2 (1.8)

7 (4.1)

  Glans

88 (44.4)

41 (36.3)

75 (43.6)

  Corpus

7 (3.5)

3 (2.7)

5 (2.9)

  Glans + foreskin and/or coronal sulcus

54 (27.3)

38 (33.6)

47 (27.3)

  Glans + corpus

40 (20.2)

29 (25.6)

37 (21.5)

  Others

1 (0.5)

0 (0.0)

1 (0.6)

  No information

2

0

1

Size (cm)

  0.6 – 2.0

18 (9.3)

9 (8.0)

17 (10.1)

  2.1 – 5.0

120 (61.9)

64 (57.1)

100 (59.2)

  5.1 – 10.0

54 (27.8)

37 (33.0)

50 (29.6)

   > 10.0

2 (1.0)

2 (1.8)

2 (1.2)

  No information

6

1

4

Macroscopic aspects

  Ulcerative

61 (30.8)

34 (30.1)

50 (29.1)

  Vegetative

46 (23.2)

34 (30.1)

44 (25.6)

  Verrucous

11 (5.6)

7 (6.2)

9 (5.2)

  Ulcerative-vegetative

51 (25.8)

28 (24.8)

44 (25.6)

  Others

29 (14.6)

10 (8.8)

25 (14.5)

  No information

2

0

1

Histological type

  Squamous cell carcinoma

200 (100.0)

113 (100.0)

173 (100.0)

Histological subtype

  Usual

79 (39.5)

44 (38.9)

65 (37.6)

  Warty

58 (29.0)

32 (28.3)

52 (30.1)

  Basaloid

8 (4.0)

6 (5.3)

8 (4.6)

  Warty-basaloid

17 (8.5)

8 (7.1)

14 (8.1)

  Mixeda

32 (16.0)

21 (18.6)

30 (17.3)

  Othersb

6 (3.0)

2 (1.8)

4 (2.3)

Grade (G)

  G1

25 (12.5)

14 (12.4)

20 (11.6)

  G2

77 (38.5)

36 (31.9)

65 (37.6)

  G3

98 (49.0)

63 (55.8)

88 (50.9)

Angiolymphatic invasion

  Detected

71 (35.5)

47 (41.6)

64 (37.0)

  Not detected

129 (64.5)

66 (58.4)

109 (63.0)

Perineural invasion

  Detected

73 (36.5)

45 (39.8)

64 (37.0)

  Not detected

127 (63.5)

68 (60.2)

109 (63.0)

Tumor focus

  Unifocal

178 (89.9)

97 (85.8)

152 (88.4)

  Multifocal

20 (10.1)

16 (14.2)

20 (11.6)

  No information

2

0

1

Carcinoma in situ—associated

  Present

164 (82.0)

92 (81.4)

143 (82.7)

  Absent

36 (18.0)

21 (18.6)

30 (17.3)

Sarcomatoid component

  Present

34 (17.1)

24 (21.2)

31 (17.9)

  Absent

165 (82.9)

89 (78.8)

142 (82.1)

  No information

1

0

0

Lichen sclerosus

  Present

53 (27.3)

27 (24.5)

44 (26.0)

  Absent

141 (72.7)

83 (75.5)

125 (74.0)

  No information

6

3

4

Koilocytosis

  Present

157 (78.5)

97 (85.8)

140 (80.9)

  Absent

43 (21.5)

16 (14.2)

33 (19.1)

Primary tumor (T)

  pT1a

42 (21.0)

16 (14.2)

35 (20.2)

  pT1b

3 (1.5)

1 (0.9)

3 (1.7)

  pT2

53 (26.5)

31 (27.4)

46 (26.6)

  pT3

96 (48.0)

61 (54.0)

84 (48.6)

  pT4

6 (3.0)

4 (3.5)

5 (2.9)

Stage

  I

42 (21.0)

16 (14.2)

35 (20.2)

  IIa

53 (26.5)

30 (26.5)

46 (26.6)

  IIb

88 (44.0)

55 (48.7)

77 (44.5)

  IIIa

1 (0.5)

0 (0.0)

1 (0.6)

  IIIb

1 (0.5)

1 (0.9)

1 (0.6)

  IV

15 (7.5)

11 (9.7)

13 (7.5)

Pattern of invasion

  Expansive

140 (75.3)

79 (73.8)

124 (75.6)

  Infiltrative

44 (23.7)

26 (24.3)

38 (23.2)

  Others

2 (1.1)

2 (1.9)

2 (1.2)

  No information

14

6

9

Tumor thickness (mm)

  ≤ 5.0

73 (39.0)

39 (35.8)

68 (41.2)

  > 5.0

114 (61.0)

70 (64.2)

97 (58.8)

  No information

13

4

8

Depth of invasion (mm)

  ≤ 5.0

97 (52.4)

53 (49.1)

89 (54.3)

  > 5.0—≤ 10.0

61 (33.0)

35 (32.4)

51 (31.1)

  > 10.0

27 (14.6)

20 (18.5)

24 (14.6)

  No information

15

5

9

  1. a Mixed tumors were: 84.4% usual and warty (n = 27); 6.3% usual, warty, and basaloid (n = 2); 6.3% usual and warty-basaloid (n = 2); 3.1% usual and basaloid (n = 1)
  2. b Other tumors were: 66.6% were pseudohiperplastic (n = 4); 16.7% medullary (n = 1); 16.7% papilar (n = 1)